Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 12 January 2009, doi:10.1136/bmj.a2597
Cite this as: BMJ 2009;338:a2597
Are widely available, but need to be standardised and used appropriately
| The first 150 words of the full text of this article appear below. |
The complete assessment of the benefits of an intervention must include evidence of the effect on the patients health status and quality of life. Such evidence is usually based on self administered or interview administered questionnaires, which are increasingly referred to as patient reported outcome measures. Two linked papers (doi:10.1136/bmj.a1190; doi:10.1136/bmj.a3006) raise important questions regarding the standardised application of these measures in randomised controlled trials. The first used several patient reported outcome measures as end points in an international study of combined hormone replacement therapy.1 The second is a systematic review of randomised trials that included the short form 36 item (SF-36) health survey questionnaire as an outcome measure.2
Two broad types of patient reported outcome measures exist—those that are specific to a disease or population and those that are generic and can be applied across populations, regardless of any underlying health problems.3 The two are
Andrew Garratt, senior researcher
1 National Resource Centre for Rehabilitation in Rheumatology, Department of Rheumatology, Diakonhjemmet Hospital, PO Box 23, 0319 Oslo, Norway
andrew.garratt@diakonsyk.no
Read all Rapid Responses